Clinic and Service Information: Details about the services offered at the Florida Surgery & Weight Loss Center, including medical weight management and other surgical options, were used to provide a complete picture of the practices offerings
Quick Answer: Zepbound does not appear to cause serious heart problems based on current clinical trial data, though gastrointestinal side effects may lead to dehydration that indirectly affects cardiovascular function
Resmetirom, which was approved by the Food and Drug Administration (FDA) in March 2024, acts hepatocentrically to accelerate -oxidation, lower atherogenic lipoproteins, and deliver early signals necessary for fibrosis regression, all while largely avoiding systemic thyrotoxic effects
It is not regulated by the FDA and it is illegal in a number of states
Pace your weight loss: Aim for slow, steady progress of around 1 to 2 pounds per week
Train With Dave said clients on the medications follow the same progressive strength work as the rest of its clients -- two to four sessions a week -- alongside that protein target and coaching on how to hit it while the medication is suppressing appetite